Knoll Capital Management, LLC Entera Bio Ltd. Transaction History
Knoll Capital Management, LLC
- $147 Million
- Q2 2025
A detailed history of Knoll Capital Management, LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Knoll Capital Management, LLC holds 5,881,879 shares of ENTX stock, worth $11.1 Million. This represents 7.6% of its overall portfolio holdings.
Number of Shares
5,881,879
Previous 5,881,879
-0.0%
Holding current value
$11.1 Million
Previous $10 Million
11.76%
% of portfolio
7.6%
Previous 6.68%
Shares
6 transactions
Others Institutions Holding ENTX
# of Institutions
21Shares Held
10.2MCall Options Held
0Put Options Held
0-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.7MShares$5.1 Million0.01% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY605KShares$1.14 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT356KShares$672,5030.09% of portfolio
-
Northern Trust Corp Chicago, IL201KShares$379,4080.0% of portfolio
-
Bessemer Group Inc Woodbridge, NJ141KShares$266,1930.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $54.5M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...